Myeloma | Tumor

CURE’s myeloma page is a go-to resource for oncology news and updates in the world of myeloma Here, readers will find cancer articles, videos, podcasts, and more with expert insight into the latest treatments and research in myeloma.

MRD Measurement Shows Promise for Making Informed Treatment Decisions in Myeloma

December 15th 2019

At CURE’s Educated Patient Summit on Multiple Myeloma, Dr. Barry Paul discussed the role of minimal residual disease measurement and how it may be used in the future to determine treatment options for patients with myeloma.

Patients with Multiple Myeloma Give Themselves Hope Through Treatment

December 15th 2019

Dr. Cesar Rodriguez offers a message of hope and self-determination for patients with multiple myeloma.

Three-Drug Combination Improves Progression-Free Survival in Patients with Multiple Myeloma

December 11th 2019

Expanding a combination from two drugs to three may lengthen the time until disease progression for patients with relapsed or refractory multiple myeloma.

CAR-T Cell Therapy That Targets Two Proteins May Help Patients with Multiple Myeloma

December 8th 2019

A dual-targeted chimeric antigen receptor-T cell therapy showed a more than 90% overall response rate in patients with relapsed or refractory disease.

Early Study Findings Lead to FDA Breakthrough Therapy Designation for CAR-T Cell Therapy to Treat Relapsed or Refractory Multiple Myeloma

December 7th 2019

JNJ-4528 showed deep responses and proved to be safe in patients with multiple myeloma, according to CARTITUDE-1 study findings.

The Importance of Clinical Trials in Multiple Myeloma

December 7th 2019

As patients progress through therapy, it is important that oncologists not disregard the novel agents that are currently being investigated in clinical trials, according to Memorial Sloan Kettering Cancer Center’s Dr. Sham Mailankody.

'Victories' After Multiple Myeloma

November 27th 2019

Meet four patients with multiple myeloma who have found hope and improved quality of life by participating in endurance events.

Friday Frontline: Cancer Updates, Research and Education on November 8, 2019

November 8th 2019

From new data released about CRISPR technology’s safety to Will Smith sharing his colonoscopy with the world, here’s what is making headlines in the cancer space this week.

Gaining Control After Cancer Unleashes its Fury

October 17th 2019

College football anchor Rod Gilmore uses his voice to help raise awareness following a multiple myeloma diagnosis.

Blood Cancer Awareness Month: What You Need to Know

September 27th 2019

For Blood Cancer Awareness Month, here’s a round-up of the latest news and updates in this disease space.

FDA Approves Frontline Darzalex Regimen to Treat Patients With Multiple Myeloma

September 26th 2019

The four-drug regimen of Darzalex in combination with Velcade, Thalomid and dexamethasone has been approved for the treatment of newly diagnosed patients with multiple myeloma who are eligible for autologous stem cell transplant.

CURE New Issue Alert: 2019 Hematology Special Issue

September 25th 2019

Here’s a look at what’s inside our 2019 Hematology special issue.

Small Steps, Big Dreams

September 19th 2019

After learning to walk again following a life-changing multiple myeloma diagnosis, Richard Bell takes on Mount Washington.

The Basics of Stem Cell Transplantation

September 19th 2019

Many patients with blood cancers may be candidates for autologous or allogeneic transplant.

Patients With Multiple Myeloma Get Shortchanged in Supportive Care

September 18th 2019

Receiving supportive care can help ease symptoms of cancer and its treatment, improving quality of life for patients. But many with multiple myeloma are missing out on aspects of this type of care, according to study findings published in Cancer.

Transforming Blood Transfusions in Cancer Treatment

September 17th 2019

New technologies boost safety for patients with cancer who need donated blood.

Reducing the Risk of Blood Clots in Patients With Multiple Myeloma

September 9th 2019

Newer treatments for multiple myeloma come with an increased risk for thrombosis, but researchers discovered five factors that could help prevent the side effect.

Cancer Blows: How Playing the Trumpet Led to One Man's Myeloma Diagnosis

August 29th 2019

CURE spoke with Ryan Anthony, a Dallas Symphony trumpet player, about how his passion for music led to his myeloma diagnosis and the start of his foundation CancerBlows.

Friday Frontline: Cancer Updates, Research and Education on August 16, 2019

August 16th 2019

From an FDA warning to real-life superheroes, here’s what is making headlines in the cancer space this week.

Friday Frontline: Cancer Updates, Research and Education on August 2, 2019

August 2nd 2019

From today’s top performers and athletes to medical aid in dying, here’s what is making headlines in the cancer space this week.

The Patient Voice Matters in Cancer Care

July 19th 2019

Researchers examined what goes into treatment decision-making for patients with multiple myeloma.

Addition of Darzalex to Chemotherapy Shows Promise in Myeloma

July 9th 2019

The use of Darzalex in combination with Revlimid, Velcade and Ozurdex demonstrated a higher percentage of stringent complete responses among transplant eligible, newly diagnosed patients with multiple myeloma.

Friday Frontline: July 5, 2019

July 5th 2019

From today’s top performers and athletes to life-threatening social media disinformation, here’s what is making headlines in the cancer space this week.

A Song for Hope

July 4th 2019

Cancer Blows, an event by The Ryan Anthony Foundation, offers hope for many with cancer – all while raising awareness for multiple myeloma.

FDA Approves Xpovio to Treat Relapsed/Refractory Multiple Myeloma

July 3rd 2019

The Food and Drug Administration has granted an accelerated approval to Xpovio in combination with dexamethasone for the treatment of adult patients with relapsed/refractory multiple myeloma who have received more than four prior therapies.

FDA Approves Frontline Darzalex/Rd in Transplant-Ineligible Myeloma

June 28th 2019

The FDA has approved the combination of Darzalex with Revlimid and dexamethasone (DRd) for the treatment of patients with newly diagnosed multiple myeloma who are ineligible for autologous stem cell transplantation.

FDA Lifts Hold on Trial Evaluating Venclexta to Treat Myeloma

June 26th 2019

The Food and Drug Administration lifted a partial clinical hold on the CANOVA trial, examining Venclexta plus dexamethasone for some patients with relapsed/refractory myeloma.

Past, Present and Future of Multiple Myeloma: How Genomics Will Play a Role

June 24th 2019

In the second part of our Q&A with Chris Williams, of the Multiple Myeloma Research Foundation, we spoke with him about the past, present and future of the myeloma landscape.

MMRF Offers Patients 'Precisely What They Need to Cure Their Disease'

June 20th 2019

In the first part of our Q&A with Chris Williams, of the Multiple Myeloma Research Foundation, we spoke with him on the current initiatives and resources available to patients.

Older Patients With Blood Cancer Should Discuss Daily Function With Their Health Care Team

June 10th 2019

Researchers determined that having difficulty performing at least one instrumental activity of daily living puts older patients at risk of death, unplanned hospitalization and emergency department visits.